Patents by Inventor Laura Calvi

Laura Calvi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230295146
    Abstract: The present disclosure provides compounds that are inhibitors of interleukin-1 receptor-associated kinases 1 and 4 (IRAK1 and IRAK4) and their use in the treatment of medical disorders such as autoimmune disorders, cancer, and pain disorders.
    Type: Application
    Filed: July 3, 2021
    Publication date: September 21, 2023
    Inventors: Michael Becker, Rakesh Singh, Richard Moore, Laura Calvi
  • Publication number: 20070281889
    Abstract: The invention relates to methods for manipulating hematopoietic stem or progenitor cells, mesenchymal stem cells, epithelial stem cells, neural stem cells and related products through activation of the PTH/PTHrP receptor in neighboring cells.
    Type: Application
    Filed: November 8, 2005
    Publication date: December 6, 2007
    Inventors: David Scadden, Laura Calvi, Gregor Adams, Henry Kronenberg
  • Publication number: 20060257376
    Abstract: The invention relates to methods for manipulating hematopoietic progenitor cells and related products. In one aspect the invention relates to the use of agents that activate a PTH/PTHrP receptor to enhance the growth and maintenance of hematopoietic progenitor cells in vivo and in vitro, to enhance mobilization of hematopoietic stem cells, to improve the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function.
    Type: Application
    Filed: July 25, 2003
    Publication date: November 16, 2006
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: David Scadden, Laura Calvi, Gregor Adams, Henry Kronenberg